Bioatla Price To Sales vs. Cash And Equivalents
| BCAB Stock | USD 1.68 0.04 2.44% |
Bioatla Price To Sales Ratio |
|
For Bioatla profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Bioatla to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Bioatla utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Bioatla's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Bioatla over time as well as its relative position and ranking within its peers.
Bioatla |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bioatla. If investors know Bioatla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bioatla listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.70) | Revenue Per Share 0.228 | Quarterly Revenue Growth 0.316 | Return On Assets (0.50) | Return On Equity (1.39) |
The market value of Bioatla is measured differently than its book value, which is the value of Bioatla that is recorded on the company's balance sheet. Investors also form their own opinion of Bioatla's value that differs from its market value or its book value, called intrinsic value, which is Bioatla's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bioatla's market value can be influenced by many factors that don't directly affect Bioatla's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bioatla's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bioatla is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bioatla's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Bioatla Cash And Equivalents vs. Price To Sales Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Bioatla's current stock value. Our valuation model uses many indicators to compare Bioatla value to that of its competitors to determine the firm's financial worth. Bioatla is rated below average in price to sales category among its peers. It is rated below average in cash and equivalents category among its peers creating about 24,123,407 of Cash And Equivalents per Price To Sales. At present, Bioatla's Price To Sales Ratio is projected to increase significantly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bioatla's earnings, one of the primary drivers of an investment's value.Bioatla Cash And Equivalents vs. Price To Sales
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Bioatla |
| = | 7.38 X |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Bioatla |
| = | 178.12 M |
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
Bioatla Cash And Equivalents Comparison
Bioatla is currently under evaluation in cash and equivalents category among its peers.
Bioatla Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Bioatla, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Bioatla will eventually generate negative long term returns. The profitability progress is the general direction of Bioatla's change in net profit over the period of time. It can combine multiple indicators of Bioatla, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Net Interest Income | 5.7 M | 6 M | |
| Interest Income | 5.7 M | 6 M | |
| Operating Income | -129.7 M | -123.2 M | |
| Net Loss | -124.1 M | -117.9 M | |
| Income Before Tax | -123.5 M | -117.3 M | |
| Total Other Income Expense Net | 6.2 M | 6.5 M | |
| Net Loss | -95.8 M | -91 M | |
| Net Loss | -123.5 M | -117.3 M | |
| Income Tax Expense | -1.1 M | -1 M | |
| Non Operating Income Net Other | 1.5 M | 1.3 M | |
| Change To Netincome | 16.8 M | 17.6 M | |
| Net Loss | (2.58) | (2.71) | |
| Income Quality | 0.84 | 0.90 | |
| Net Income Per E B T | 1.14 | 1.12 |
Bioatla Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Bioatla. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Bioatla position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Bioatla's important profitability drivers and their relationship over time.
Use Bioatla in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bioatla position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bioatla will appreciate offsetting losses from the drop in the long position's value.Bioatla Pair Trading
Bioatla Pair Trading Analysis
The ability to find closely correlated positions to Bioatla could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bioatla when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bioatla - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bioatla to buy it.
The correlation of Bioatla is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bioatla moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bioatla moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bioatla can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Bioatla position
In addition to having Bioatla in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Plastics Thematic Idea Now
Plastics
Companies manufacturing rubber and plastics accessories. The Plastics theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Plastics Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities. For information on how to trade Bioatla Stock refer to our How to Trade Bioatla Stock guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
To fully project Bioatla's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Bioatla at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Bioatla's income statement, its balance sheet, and the statement of cash flows.